RESUMEN

PURPOSE: Effective treatment of neuropathic pain without unacceptable side effects is challenging. Cancer sufferers increasingly live with long-term treatment-related neuropathic pain, resulting from chemotherapy-induced peripheral neuropathy (CIPN) or surgical scars. This proof-of-concept study aimed to determine whether preclinical evidence for TRPM8 ion channels in sensory neurons as a novel analgesic target could be translated to clinical benefit in patients with neuropathic pain, using the TRPM8 activator menthol. PATIENTS AND METHODS: Patients with problematic treatment-related neuropathic pain underwent a baseline assessment using validated questionnaires, psychophysical testing, and objective functional measures. The painful area was treated with topical 1 % menthol cream twice daily. Assessments were repeated at 4-6 weeks. The primary outcome was the change in Brief Pain Inventory total scores at 4-6 weeks. Secondary outcomes included changes in function, mood and skin sensation. RESULTS: Fifty-one patients (female/male, 32/19) were recruited with a median age of 61 (ranging from 20 to 89). The commonest aetiology was CIPN (35/51), followed by scar pain (10/51). Thirty-eight were evaluable on the primary outcome. Eighty-two per cent (31/38) had an improvement in total Brief Pain Inventory scores (median, 47 (interquartile range, 30 to 64) to 34 (6 to 59), P < 0.001). Improvements in mood (P = 0.0004), catastrophising (P = 0.001), walking ability (P = 0.008) and sensation (P < 0.01) were also observed. CONCLUSION: This proof-of-concept study indicates that topical menthol has potential as a novel analgesic therapy for cancer treatment-related neuropathic pain. Improvements in patient-rated measures are supported by changes in objective measures of physical function and sensation. Further systematic evaluation of efficacy is required.

Asunto(s)

Analgésicos/uso terapéutico , Antineoplásicos/efectos adversos , Mentol/uso terapéutico , Neoplasias/tratamiento farmacológico , Neuralgia/tratamiento farmacológico , Canales Catiónicos TRPM/agonistas , Administración Tópica , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neuralgia/inducido químicamente , Neuralgia/psicología , Encuestas y Cuestionarios , Resultado del Tratamiento , Adulto Joven

RESUMEN

Cancer-induced bone pain (CIBP) is a major clinical problem with up to 85% of patients with bony metastases having pain, often associated with anxiety and depression, reduced performance status, and a poor quality of life. Malignant bone disease creates a chronic pain state through sensitization and synaptic plasticity within the spinal cord that amplifies nociceptive signals and their transmission to the brain. Fifty per cent of patients are expected to gain adequate analgesia from palliative radiotherapy within 4-6 weeks of treatment. Opioid analgesia does make a useful contribution to the management of CIBP, especially in terms of suppressing tonic background pain. However, CIBP remains a clinical challenge because the spontaneous and movement-related components are more difficult to treat with opioids and commonly used analgesic drugs, without unacceptable side-effects. Recently developed laboratory models of CIBP, which show congruency with the clinical syndrome, are contributing to an improved understanding of the neurobiology of CIBP. This chronic pain syndrome appears to be unique and distinct from other chronic pain states, such as inflammatory or neuropathic pain. This has clear implications for treatment and development of future therapies. A translational medicine approach, using a highly iterative process between the clinic and the laboratory, may allow improved understanding of the underlying mechanisms of CIBP to be rapidly translated into real clinical benefits in terms of improved pain management.

Asunto(s)

Neoplasias Óseas/complicaciones , Dolor/etiología , Analgesia/métodos , Animales , Neoplasias Óseas/secundario , Enfermedad Crónica , Modelos Animales de Enfermedad , Humanos , Dolor/tratamiento farmacológico

RESUMEN

Cooling of the skin has long been thought to be beneficial in pain states but intense cold is clearly noxious. Does cooling lead to pain or gain? Rapid progress in this controversy has been made since the discovery of specific ion channels of the transient receptor potential (TRP) family that are activated by cooling of sensory nerve cells to below body temperature. This review focuses on the role of one of these, TRPM8, which has been implicated in cool sensation and cold pain by recent knockout mouse studies, but remarkably also appears capable of eliciting a novel analgesic gating control over noxious inputs in chronic pain states. We discuss hypothetical mechanisms that could bring about this composite profile. It is clear that new and highly selective agents will need to be developed to further evaluate the potential therapeutic opportunities offered by low temperature sensitive TRP channels.

Asunto(s)

Frío , Manejo del Dolor , Animales , Canales de Calcio/fisiología , Humanos , Proteínas de la Membrana/fisiología , Proteínas del Tejido Nervioso/fisiología , Dolor/fisiopatología , Sensación , Canal Catiónico TRPA1 , Canales Catiónicos TRPM/fisiología , Canales Catiónicos TRPV/fisiología , Canales de Potencial de Receptor Transitorio

RESUMEN

BACKGROUND: Sucking may reduce the manifestations of pain in newborn infants. OBJECTIVE: To examine the effect of suckling on the threshold for peripheral somatosensory responses. SUBJECTS AND METHODS: Graded Von Frey filaments were applied to the heel to initiate peripheral somatosensory responses (withdrawal reflex and gross body movements) in term infants. RESULTS: Dummy sucking increases the somatosensory threshold, but breast feeding had a more marked effect, increasing the threshold of the flexion withdrawal reflex (p

Asunto(s)

Recién Nacido/fisiología , Umbral del Dolor/fisiología , Conducta en la Lactancia/fisiología , Lactancia Materna , Talón , Humanos , Movimiento/fisiología , Chupetes , Estimulación Física/métodos , Postura/fisiología , Reflejo/fisiología

RESUMEN

Activation of intracellular signaling pathways involving p38 and p42/44 MAP kinases may contribute importantly to synaptic plasticity underlying spinal neuronal sensitization. Inhibitors of p38 or p42/44 pathways moderately attenuated responses of dorsal horn neurons evoked by mustard oil but not brush and alleviated the behavioral reflex sensitization seen following nerve injury. Activation of p38 and p42/44 MAP kinases in spinal cord ipsilateral to constriction injury was reduced by antagonists of NMDA, VPAC2 and NK2 (but not related) receptors, the glial inhibitor propentofylline and inhibitors of TNF-alpha. A VPAC2 receptor agonist enhanced p38 phosphorylation and caused behavioral reflex sensitization in naïve animals that could be blocked by co-administration of p38 inhibitor. Conversely, an NK2 receptor agonist activated p42/44 and caused behavioral sensitization that could be prevented by co-administration of p42/44 inhibitor. Thus, spinal p38 and p42/44 MAP kinases are activated in neuropathic pain states by mechanisms involving VPAC2, NK2, NMDA receptors and glial cytokine production.

Asunto(s)

Sistema de Señalización de MAP Quinasas/fisiología , Neuroglía/metabolismo , Enfermedades del Sistema Nervioso Periférico/metabolismo , Células del Asta Posterior/metabolismo , Receptores de Neuroquinina-2/metabolismo , Receptores de Tipo II del Péptido Intestinal Vasoactivo/metabolismo , Animales , Modelos Animales de Enfermedad , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Inhibidores Enzimáticos/farmacología , Mediadores de Inflamación/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Proteína Quinasa 1 Activada por Mitógenos/efectos de los fármacos , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Neuralgia/metabolismo , Neuralgia/fisiopatología , Neuroglía/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Traumatismos de los Nervios Periféricos , Nervios Periféricos/metabolismo , Nervios Periféricos/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Fosforilación/efectos de los fármacos , Estimulación Física , Células del Asta Posterior/efectos de los fármacos , Ratas , Ratas Wistar , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/metabolismo , Receptores de Neuroquinina-2/efectos de los fármacos , Receptores de Tipo II del Péptido Intestinal Vasoactivo/efectos de los fármacos , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismo , Xantinas/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo

RESUMEN

Some opioid-resistant pain conditions can be alleviated by voltage-dependent Na(+) channel blockers such as lamotrigine. The mu-opioid-receptor agonist morphine can modulate cation entry into cells to affect overall cellular excitability, an effect which can in turn be endogenously antagonised by the neuropeptide cholecystokinin (CCK). However, lamotrigine may also modulate cellular excitability by non-specifically blocking voltage-dependent ion channels. We have looked for interactions of lamotrigine with the opioid/CCK pathway within the spinal dorsal horn, to rule out the possibility that lamotrigine may attenuate nociceptive responses via actions on this pathway. Both lamotrigine and the mu-opioid agonist DAMGO inhibited mustard oil-evoked cell firing by approximately 50% compared with control levels. Co-application of CCK8S reversed DAMGO-, but not lamotrigine-induced inhibition of cell firing and this reversal was prevented with the selective CCK(B) receptor antagonist PD 135158. Although lamotrigine inhibited both brush- and cold-evoked cell firing in neuropathic animals, lamotrigine inhibition of mustard oil-evoked cell firing in the same animals was not significantly greater than that observed in controls. These results suggest that the antinociceptive properties of lamotrigine within the spinal dorsal horn are unlikely to be mediated via interactions with the opioid/CCK pathway.

Asunto(s)

Bloqueadores de los Canales de Calcio/farmacología , Vías Nerviosas/efectos de los fármacos , Nociceptores/efectos de los fármacos , Péptidos Opioides/metabolismo , Dolor/tratamiento farmacológico , Células del Asta Posterior/efectos de los fármacos , Triazinas/farmacología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Analgésicos Opioides/farmacología , Animales , Ansiolíticos/farmacología , Colecistoquinina/metabolismo , Encefalina Ala(2)-MeFe(4)-Gli(5)/farmacología , Indoles/farmacología , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Inflamación/fisiopatología , Lamotrigina , Masculino , Meglumina/análogos & derivados , Meglumina/farmacología , Planta de la Mostaza , Vías Nerviosas/citología , Vías Nerviosas/metabolismo , Nociceptores/citología , Nociceptores/metabolismo , Dolor/metabolismo , Dolor/fisiopatología , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/metabolismo , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Extractos Vegetales/farmacología , Aceites de Plantas , Células del Asta Posterior/citología , Células del Asta Posterior/metabolismo , Ratas , Ratas Wistar , Sincalida/farmacología

RESUMEN

The Prx gene in Schwann cells encodes L- and S-periaxin, two abundant PDZ domain proteins thought to have a role in the stabilization of myelin in the peripheral nervous system (PNS). Mice lacking a functional Prx gene assemble compact PNS myelin. However, the sheath is unstable, leading to demyelination and reflex behaviors that are associated with the painful conditions caused by peripheral nerve damage. Older Prx-/- animals display extensive peripheral demyelination and a severe clinical phenotype with mechanical allodynia and thermal hyperalgesia, which can be reversed by intrathecal administration of a selective NMDA receptor antagonist We conclude that the periaxins play an essential role in stabilizing the Schwann cell-axon unit and that the periaxin-deficient mouse will be an important model for studying neuropathic pain in late onset demyelinating disease.

Asunto(s)

Conducta Animal , Enfermedades Desmielinizantes/complicaciones , Proteínas de la Membrana/deficiencia , Dolor/etiología , Dolor/psicología , Enfermedades del Sistema Nervioso Periférico/complicaciones , Animales , Axones/ultraestructura , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/patología , Electrofisiología , Antagonistas de Aminoácidos Excitadores/farmacología , Humanos , Hiperalgesia/genética , Hiperalgesia/fisiopatología , Proteínas de la Membrana/genética , Trastornos Mentales/etiología , Ratones , Ratones Noqueados/genética , Conducción Nerviosa , Nervios Periféricos/fisiopatología , Enfermedades del Sistema Nervioso Periférico/genética , Enfermedades del Sistema Nervioso Periférico/patología , Células de Schwann/ultraestructura , Trastornos Somatosensoriales/genética , Trastornos Somatosensoriales/fisiopatología

RESUMEN

Following the establishment of a chronic varicella-zoster virus infection in the rat, behavioural allodynia and hyperalgesia were observed in the injected, but not the contralateral hind limb up to 33 days post-infection. This model may prove useful in investigating mechanisms involved in the establishment of post-herpetic neuralgia.

Asunto(s)

Conducta Animal , Herpes Zóster/psicología , Animales , Herpes Zóster/fisiopatología , Hiperalgesia , Masculino , Dolor/fisiopatología , Ratas , Ratas Wistar , Proteínas Virales/análisis

RESUMEN

Neuropathic pain arising from direct trauma to, or compression injury of, peripheral nerves is a common clinical problem. It is characterized by the development of abnormal pain states (spontaneous pain, hyperalgesia, allodynia), which can persist long after the initial injury has resolved. The underlying mechanisms are poorly understood and, as a consequence, treatment is often unsatisfactory. Some of the main contributing factors are thought to be the morphological and phenotypic changes that occur centrally, including alterations in the expression of neurotransmitters and their associated receptors, both in the dorsal root ganglia and in the spinal dorsal horn. This article focuses on the functional role of the two structurally related peptides VIP and PACAP within the spinal cord, and their possible contribution to the altered transmission of sensory information in neuropathic conditions.

Asunto(s)

Neuropéptidos/fisiología , Dolor/fisiopatología , Traumatismos de los Nervios Periféricos , Sistemas de Mensajero Secundario/fisiología , Médula Espinal/química , Péptido Intestinal Vasoactivo/fisiología , Animales , Ganglios Espinales/química , Dolor/etiología , Nervios Periféricos/patología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Ratas , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria , Receptores de la Hormona Hipofisaria/fisiología , Receptores de Péptido Intestinal Vasoactivo/fisiología , Receptores de Tipo II del Péptido Intestinal Vasoactivo , Receptores de Tipo I del Polipéptido Intestinal Vasoactivo , Sistemas de Mensajero Secundario/efectos de los fármacos

RESUMEN

Neuropathic pain is thought to arise from ectopic discharges at the site of injury within the peripheral nervous system, and is manifest as a general increase in the level of neuronal excitability within primary afferent fibres and their synaptic contacts within the spinal cord. Voltage-activated Na+ channel blockers such as lamotrigine have been shown to be clinically effective in the treatment of neuropathic pain. Na+ channels are structurally diverse comprising a principal a subunit (of which there are variable isoforms) and two auxiliary subunits termed beta1 and beta2. Both beta subunits affect the rates of channel activation and inactivation, and can modify alpha subunit density within the plasma membrane. In addition, these subunits may interact with extracellular matrix molecules to affect growth and myelination of axons. Using in situ hybridization histochemistry we have shown that the expression of the beta1 and beta2 subunits within the dorsal horn of the spinal cord of neuropathic rats is differentially regulated by a chronic constrictive injury to the sciatic nerve. At days 12-15 post-neuropathy, beta1 messenger RNA levels had increased, whereas beta2 messenger RNA levels had decreased significantly within laminae I, II on the ipsilateral side of the cord relative to the contralateral side. Within laminae III-IV beta2 messenger RNA levels showed a small but significant decrease on the ipsilateral side relative to the contralateral side, whilst expression of beta1 messenger RNA remained unchanged. Thus, differential regulation of the individual beta subunit types may (through their distinct influences on Na+ channel function) contribute to altered excitability of central neurons after neuropathic injury.

Asunto(s)

Ganglios Espinales/fisiopatología , Regulación de la Expresión Génica/efectos de los fármacos , Hiperalgesia/fisiopatología , Canales de Sodio/biosíntesis , Médula Espinal/metabolismo , Animales , Frío , Ganglios Espinales/efectos de los fármacos , Hiperalgesia/genética , Procesamiento de Imagen Asistido por Computador , Hibridación in Situ , Activación del Canal Iónico/efectos de los fármacos , Transporte Iónico/efectos de los fármacos , Masculino , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Ratas , Ratas Wistar , Canales de Sodio/química , Canales de Sodio/genética , Médula Espinal/fisiopatología , Tetrodotoxina/farmacología , Péptido Intestinal Vasoactivo/biosíntesis , Péptido Intestinal Vasoactivo/genética

RESUMEN

Peripheral nerve damage often results in the development of chronic pain states, resistant to classical analgesics. Since vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are up-regulated in dorsal root ganglion cells following peripheral nerve injury, we investigated the expression and influence of VPAC1, VPAC2 and PAC1 receptors in rat spinal dorsal horn following a chronic constriction injury (CCI). Electrophysiological studies revealed that selective antagonists of VPAC1, VPAC2 and PAC1 receptors inhibit mustard oil-, but not brush-induced activity of dorsal horn neurones in CCI animals, while cold-induced neuronal activity was attenuated by VPAC1 and PAC1, but not VPAC2 receptor antagonists. Ionophoresis of selective agonists for the receptor subtypes revealed that the VPAC2 receptor agonist excited twice as many cells in CCI compared to normal animals, while the number of cells excited by the VPAC1 receptor agonist decreased and responses to PACAP-38 remained unchanged. In situ hybridisation histochemistry (ISHH) confirmed an increase in the expression of VPAC2 receptor mRNA within the ipsilateral dorsal horn following neuropathy, while VPAC1 receptor mRNA was seen to decrease and that for PAC1 receptors remained unchanged. These data indicate that VIP/PACAP receptors may be important regulatory factors in neuropathic pain states.

Asunto(s)

Neuralgia/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Receptores de la Hormona Hipofisaria/fisiología , Receptores de Péptido Intestinal Vasoactivo/fisiología , Sensación/fisiología , Médula Espinal/fisiopatología , Animales , Conducta Animal/fisiología , Potenciales Evocados Somatosensoriales/fisiología , Histocitoquímica/métodos , Hibridación in Situ , Masculino , Neuronas/efectos de los fármacos , Neuronas/fisiología , Enfermedades del Sistema Nervioso Periférico/etiología , Ratas , Ratas Wistar , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria , Receptores de la Hormona Hipofisaria/agonistas , Receptores de Péptido Intestinal Vasoactivo/agonistas , Receptores de Tipo II del Péptido Intestinal Vasoactivo , Receptores de Tipo I del Polipéptido Intestinal Vasoactivo , Médula Espinal/efectos de los fármacos , Estrés Mecánico , Regulación hacia Arriba

RESUMEN

Electrophysiological and behavioral studies point to a role of group I metabotropic glutamate receptors (mGluR1 and mGluR5) in mediating spinal nociceptive responses in rats. However, antagonists with a high degree of specificity for each of these sites are not yet available. We, therefore, examined the effects of antisense deletion of spinal mGluR1 expression in assays of behavioral analgesia and of electrophysiological responses of dorsal horn neurons. Rats treated with an mGluR1 antisense oligonucleotide reagent, delivered continuously to the intrathecal space of the lumbar spinal cord, developed marked analgesia as measured by an increase in the latency to tail-flick (55 degreesC) over a period of 4-7 d. This correlated with a selective reduction in mGluR1, but not mGluR5, immunoreactivity in the superficial dorsal horn compared with untreated control rats, in parallel with a significant reduction in the proportion of neurons activated by the mGluR group I agonist 3, 5-dihydroxyphenylglycine (DHPG), whereas the proportion of cells excited by the mGluR5 agonist, trans-azetidine-2,4-dicarboxylic acid (t-ADA) remained unaffected. In contrast, rats treated with mGluR1 sense or mismatch probes showed none of these changes compared with untreated, control rats. Furthermore, multireceptive dorsal horn neurons in mGluR1 antisense-treated rats were strongly excited by innocuous stimuli to their peripheral receptive fields, but showed severe reductions in their sustained excitatory responses to the selective C-fiber activator mustard oil and in responses to DHPG.

Asunto(s)

Nociceptores/fisiología , Receptores de Glutamato Metabotrópico/genética , Médula Espinal/citología , Médula Espinal/fisiología , Transmisión Sináptica/fisiología , Animales , Elementos sin Sentido (Genética) , Ácido Azetidinocarboxílico/análogos & derivados , Ácido Azetidinocarboxílico/farmacología , Conducta Animal/fisiología , Electrofisiología , Agonistas de Aminoácidos Excitadores/farmacología , Eliminación de Gen , Glicina/análogos & derivados , Glicina/farmacología , Masculino , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Mutagénesis/fisiología , Ratas , Ratas Wistar , Receptor del Glutamato Metabotropico 5 , Resorcinoles/farmacología , Transmisión Sináptica/efectos de los fármacos

Asunto(s)

Analgesia , Neuropéptidos/fisiología , Receptores de Neuropéptido/agonistas , Receptores de Neuropéptido/antagonistas & inhibidores , Animales , Animales Modificados Genéticamente , Humanos , Enfermedades Neurodegenerativas/tratamiento farmacológico , Neuropéptidos/farmacología , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria , Receptores de la Hormona Hipofisaria/efectos de los fármacos , Receptores de Péptido Intestinal Vasoactivo/efectos de los fármacos , Sustancia P/antagonistas & inhibidores , Transmisión Sináptica/efectos de los fármacos

RESUMEN

Activation of spinal neurokinin1 (NK1) receptors leads to increases in the extracellular concentration of glycine in the dorsal horn. We have investigated the role of the inhibitory glycine receptor as a regulator of NK1 receptor-mediated effects on dorsal horn neurones. Ionophoretic application of GR82334, a selective NK1 antagonist, did not alter dorsal horn neuronal activity evoked by cutaneous applications of mustard oil. However, in the presence of the glycine antagonists, strychnine or phenylbenzene-omega-phosphono-alpha-amino acid (PMBA), GR82334 displayed inhibitory properties. Therefore inhibitory glycine receptors may mask the contribution made by NK1 receptors to nociceptive processing. This is discussed with reference to the role of NK1 receptors during brief and long duration nociceptive transmission.

Asunto(s)

Neuronas/fisiología , Receptores de Glicina/fisiología , Receptores de Neuroquinina-1/fisiología , Médula Espinal/fisiología , Animales , Iontoforesis , Masculino , Fosforilación , Fisalemina/análogos & derivados , Fisalemina/farmacología , Ratas , Ratas Wistar , Médula Espinal/citología

RESUMEN

Two voltage-activated Na+ channel blockers, lamotrigine and flunarizine were applied ionophoretically to extracellularly recorded dorsal horn neurones to assess effects on activation by noxious (mustard oil) and innocuous (brush) stimuli. Lamotrigine and flunarizine caused significantly greater reductions in mustard oil-evoked activity (> 50% in both cases) than in brush-evoked activity (13 +/- 7% and 29 +/- 6%; p < 6%; +/- 0.005 and p < 0.05 respectively) at equivalent ionophoretic currents. Similar results were observed when lamotrigine was administered i.v. Thus, the activation of dorsal horn neurones by nociceptive and non-nociceptive afferent inputs can be differentiated by the blockade of a lamotrigine/flunarizine-sensitive Na+ channel, at a spinal site.

Asunto(s)

Analgésicos/farmacología , Potenciales Evocados Somatosensoriales/efectos de los fármacos , Flunarizina/farmacología , Ganglios Espinales/efectos de los fármacos , Bloqueadores de los Canales de Sodio , Triazinas/farmacología , Animales , Relación Dosis-Respuesta a Droga , Glutamatos/farmacología , Lamotrigina , Masculino , Planta de la Mostaza , Estimulación Física , Extractos Vegetales/farmacología , Aceites de Plantas , Plantas Medicinales , Ratas , Ratas Wistar

RESUMEN

The extracellularly recorded electrophysiological activity of single multireceptive dorsal horn neurons was markedly increased by ionophoretic administration of vasoactive intestinal polypeptide (VIP) or pituitary adenylate cyclase activating polypeptide (PACAP)-38. Some cells responded selectively to PACAP-38 (suggesting mediation by a PACAP receptor), whereas others responded to both VIP and PACAP-38 (suggesting a VIP1 and/or VIP2 receptor). Most non-nociceptive cells were unaffected by PACAP-38 and all were unaffected by VIP. The selectivity of VIP/PACAP receptor antagonists was established on cloned rat VIP1, VIP2 and PACAP receptors in vitro before their utilization to indicate the likely involvement of VIP1, and possibly PACAP receptors, in VIP- and PACAP-38-mediated responses of dorsal horn neurons. The VIP/PACAP receptor antagonists inhibited responses of multireceptive cells to sustained innocuous (brush) and noxious (mustard oil) stimuli, with a selectivity suggesting the involvement of VIP1 and PACAP receptors, although the participation by VIP2 receptors cannot be excluded. These data implicate both VIP and PACAP in regulating the basal responsiveness of multireceptive dorsal horn neurons to sensory stimuli.

Asunto(s)

Neuronas Aferentes/fisiología , Neuronas/fisiología , Neuropéptidos/farmacología , Neurotransmisores/farmacología , Receptores de la Hormona Hipofisaria/fisiología , Receptores de Péptido Intestinal Vasoactivo/fisiología , Médula Espinal/fisiología , Péptido Intestinal Vasoactivo/farmacología , Animales , Células COS , Masculino , Potenciales de la Membrana/efectos de los fármacos , Neuronas/efectos de los fármacos , Fragmentos de Péptidos/farmacología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Ratas , Ratas Wistar , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria , Receptores de la Hormona Hipofisaria/efectos de los fármacos , Receptores de Péptido Intestinal Vasoactivo/efectos de los fármacos , Receptores de Tipo II del Péptido Intestinal Vasoactivo , Proteínas Recombinantes/metabolismo , Médula Espinal/efectos de los fármacos , Transfección , Péptido Intestinal Vasoactivo/análogos & derivados

RESUMEN

We have investigated the role of the glycine recognition site of the N-methyl-D-aspartate receptor (the GlyNMDA site) in the facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons that is brought about by neurokinin1 (NK1) receptor agonist and the contribution of protein kinase C (PKC) activation to this phenomenon. Ionophoresis of the selective NMDA receptor agonist 1-aminocyclobutane-cis-1,3-dicarboxylic acid (ACBD) produced a sustained increase in the firing rate of single laminae III-V neurons recorded extracellularly using multibarrelled glass electrodes. The highly selective NK1 receptor agonist acetyl-[Arg6,Sar9,Met(O2)11]-SP6-11 (Sar9-SP) greatly facilitated this response, but under the present conditions had no effect when applied alone or with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor agonist) at the same current. In the presence of the GLyNMDA site antagonists 2-carboxy-4,6-dichloro-(1H)-indole-3-propanoic acid (MDL 29951), 7-chloro-3-(cyclopropylcarbonyl)-4-hydroxy-2(1H)-quinoline (L701,252), 5,7-dinitroquinaxoline-2,3-dione (MNQX) or 7-chlorothiokynurenic acid (7-CTK), or the PKC inhibitors, chelerythrine or GF109203X, the Sar9-SP-induced facilitation of ACBD-evoked activity was prevented, generally restoring activity to a level similar to that in the presence of ACBD alone, whilst an AMPA receptor antagonist, 6-nitro-7-sulfamoylbenzo(f)quinoxaline-2,3-dione (NBQX) did not inhibit the facilitation. At the same ionophoretic currents these compounds had no effect on ACBD-evoked activity in the absence of Sar9-SP but were inhibitory at significantly greater currents. To further substantiate the importance of the GlyNMDA site in the interaction, the effects of NMDA receptor antagonists selective for alternative recognition sites on the NMDA receptor were investigated. MK-801, a non-competitive NMDA receptor antagonist and arcaine, a competitive inhibitor at the polyamine site, were applied to the facilitated activity seen in the presence of Sar9-SP and ACBD, and to ACBD-evoked activity alone. Unlike the GlyNMDA site antagonists and PKC inhibitors, these compounds reduced both facilitated and ACBD-evoked activity at similar currents. Furthermore, like the NK1 receptor agonist, a selective GlyNMDA site agonist 1-aminocyclopropane carboxylic acid (ACPC) caused facilitation of ACBD-evoked activity which was also blocked by currents of L701,252 that did not alter activity evoked by ACBD alone. These data suggest that activation of the GlyNMDA site (perhaps as a consequence of glycine release or modification of its influence by intracellular signalling cascades) is an essential component of the means by which NK1 receptor activation results in facilitated responsiveness of dorsal horn neurons towards NMDA receptor agonists.

Asunto(s)

Ganglios Espinales/efectos de los fármacos , Glicina/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Receptores de Neuroquinina-1/agonistas , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/farmacología , Animales , Masculino , Ratas , Ratas Wistar

RESUMEN

A combined study of behavioural and electrophysiological tests was carried out in order to assess the role of metabotropic glutamate receptors (mGluRs) in mediating sensory inputs to the spinal cord of the rat. In the behavioural study the responses of conscious animals, with or without carrageenan-induced inflammation, to noxious mechanical and thermal stimuli were observed both before and after the intrathecal administration of mGluR antagonists L(+)-2-amino-3-phosphonopropionic acid (L-AP3) and (S)-4-carboxy-3-hydroxyphenylglycine (CHPG). It was found that the mGluR antagonist (S)-CHPG was capable of increasing both mechanical threshold and thermal latency in both groups of animals, and L-AP3 did so in those with inflammation induced in their hindpaw. Following this study, the responses of single lamina III-V dorsal horn neurons to an innocuous A beta fibre brush stimulus and a noxious C fibre (mustard oil) stimulus were extracellularly recorded and the effect of ionophoretically applied drugs was examined. Cyclothiazide (CTZ), a selective antagonist at mGluR1, markedly reduced the activity evoked by mustard oil, but not that elicited by brushing of the receptive field. Activity induced in dorsal horn neurons by ionophoresing various mGluR subgroup agonists was examined. CTZ successfully inhibited the activity evoked by group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG). In comparison to the neurons which responded to the ionophoresis of DHPG, less were activated by the selective mGluR5 agonist trans-azetidine dicarboxylic acid (t-ADA). Together these results indicate that group I mGlu receptors, in particular mGluR1, play a crucial role in mediating nociception, particularly following a sustained noxious input.

Asunto(s)

Conducta Animal/fisiología , Nociceptores/fisiología , Dolor/fisiopatología , Receptores de Glutamato Metabotrópico/fisiología , Médula Espinal/fisiología , Alanina/análogos & derivados , Alanina/farmacología , Animales , Antihipertensivos/farmacología , Benzotiadiazinas/farmacología , Cicloleucina/análogos & derivados , Cicloleucina/farmacología , Electrofisiología , Antagonistas de Aminoácidos Excitadores/farmacología , Femenino , Glicina/análogos & derivados , Glicina/farmacología , Masculino , Planta de la Mostaza , Fármacos Neuroprotectores/farmacología , Nociceptores/efectos de los fármacos , Fenilacetatos/farmacología , Extractos Vegetales , Aceites de Plantas , Plantas Medicinales , Ratas , Ratas Endogámicas , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores , Resorcinoles/farmacología , Médula Espinal/química

RESUMEN

The excitatory responses of individual dorsal horn neurons to cutaneous brush, repeated application of the C-fibre-selective chemical algogen, mustard oil, or to ionophoretic (1S,3R)-ACPD [a metabotropic glutamate receptor (mGluR) agonist] were monitored by extracellular recording. We have previously shown that the responses of dorsal horn neurons to mustard oil are inhibited by several selective antagonists of mGluRs. Effects of ionophoresis of the mGluR antagonists (R,S)-CHPG and L-AP3 and a range of selective inhibitors of intracellular signalling pathways were examined on evoked responses here. The results suggest that protein kinase C, phospholipase A2 and perhaps Ca2+/calmodulin kinase II play a role in mediating the sustained elevated activity of dorsal horn neurons that is incrementally elicited by repeated application of mustard oil, but probably make little contribution to sustained brush-evoked activity. Concurrence in the sensitivity of mustard oil- and (1S,3R)-ACPD-evoked activity to (R,S)-CHPG, L-AP3 and to inhibitors of intracellular signalling pathways, suggests that mGluRs are an important origin of these intracellular signals required for sustained nociception.

Asunto(s)

Neuronas/fisiología , Dolor/fisiopatología , Receptores de Glutamato Metabotrópico/fisiología , Médula Espinal/fisiología , Transmisión Sináptica/fisiología , Animales , Cicloleucina/análogos & derivados , Cicloleucina/farmacología , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/fisiología , Técnicas In Vitro , Iontoforesis , Masculino , Planta de la Mostaza , Neuronas/efectos de los fármacos , Dolor/inducido químicamente , Estimulación Física , Extractos Vegetales , Aceites de Plantas , Ratas , Ratas Wistar , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Médula Espinal/citología , Médula Espinal/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacos

RESUMEN

The intracellular mechanisms involved in the sensitisation of spinal dorsal horn neurons brought about by sustained or repeated nociceptive inputs are unknown. The present experiments addressed any role of protein kinase (PKC) in sustained nociceptive responses of rat dorsal horn neurons by: (i) ionophoretic administration of PKC inhibitors whilst recording activity evoked by repeated cutaneous application of mustard oil; and (ii) assessing subcellular translocation of PKC evoked in spinal cord by cutaneous application of mustard oil. Both marked attenuation of mustard oil-induced neuronal activity by PKC inhibitors and selective translocation of PKC in spinal cord tissue ipsilateral to mustard oil application strongly supported a critical role of PKC in sustained nociceptive responses to mustard oil.

Asunto(s)

Neuronas/efectos de los fármacos , Extractos Vegetales/farmacología , Proteína Quinasa C/fisiología , Médula Espinal/efectos de los fármacos , Administración Cutánea , Animales , Sitios de Unión/efectos de los fármacos , Membrana Celular/metabolismo , Citosol/metabolismo , Masculino , Planta de la Mostaza , Neuronas/fisiología , Forbol 12,13-Dibutirato/metabolismo , Aceites de Plantas , Ratas , Ratas Wistar , Médula Espinal/citología , Médula Espinal/fisiología